Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer
Clinical trial NCT03908671 · UNKNOWN
Trial details
- NCT number
- NCT03908671
- Sponsor
- Stemirna Therapeutics
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-18
- Primary completion
- 2024-10-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.